Login

Adelene Pewrkins, CEO, Infinity Pharmaceuticals Inc 00:00:00

Share On Facebook Share On Twitter

Adelene Perkins (Infinity Pharmaceuticals) Shares Career Advice

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Rogers Corporation CEO Bruce Hoechner discusses the company's Code of Business Ethics.
00:10:00
Presentation by Kay Quinoa, CEO of Tier Two Minerals Limited
00:10:00
HARNESSING THE POWER OF SCIENCE GLOBALLY|Carlo Rizzuto,Managing Director,Versant Ventures
00:10:00
Host TK Kerstetter interviews Sara Hays, Board Member of Apogee Enterprises Inc., discussing research that suggests corporate directors who serve at multiple companies bring valuable perspectives and experience.|Ty R. Silberhorn. Chief Executive Officer,
00:10:00
Enterprise Mobility of DecisionPoint is Moving Decisions Closer to the Customer | Nicholas Toms, CEO, DecisionPoint Systems IncDPSI:ASQ
00:10:00
The Surge in Iraq: Strategy, Challenges, and Successes|Jack Keane
00:10:00
Revolutionizing Mining: Real-Time Data and Ventilation On-Demand Enhance Safety and Efficiency
00:10:00
Demystifying Impact Investing: Insights from Tom Mitchell |Tom Mitchell, Managing Director, Cambridge Associates LLC.
00:10:00
The Franco Regime: Legacy and Contemporary Perspectives|Stanley G. Payne,Professor,University of Wisconsin-Madison
00:10:00
Advancing Energy and Environmental Solutions: Insights from Babcock & Wilcox Executives | Babcock & Wilcox executives; Mohammed Helwee, Regional Director of Business Development and Sales
00:10:00
Exploring Potential: Casino Resources' Nickel-Copper Project at One-to-One Mining Conference in London
00:10:00
Hot Chile Limited: Overview of Costa Fuego and Cordadera Discoveries

© 2026 Nehu